For
immediate
release
4 October 2024
CVS GROUP
plc
("CVS", the "Company" or the
"Group")
Long Term Incentive Plan
Awards and PDMR Dealing
CVS, the UK listed veterinary group
and a leading provider of veterinary services, announces that it
has granted option awards over a total of 197,820 of the Company's
ordinary shares of 0.2 pence each ("Ordinary Shares")
under the CVS Group Long Term Incentive Plan 2024 ("LTIP 18") (the
"Options"). Certain of the Options were awarded to the
Directors named below, with the balance being issued to certain
other employees.
Name Role Number
of Options
Richard Fairman
Chief Executive
Officer
55,581
Robin
Alfonso
Chief Financial
Officer
30,460
Paul
Higgs
Chief Veterinary Officer
26,144
The awards will vest in three years'
time, subject to performance criteria being satisfied. These
vesting criteria relate to the Company's earnings per share growth
and total shareholder return over the three-year period
between 1 July 2024 and 30 June 2027.
The notification below, made in
accordance with the requirements of UK MAR, provides further
detail.
CVS
Group
plc
via
Camarco
Richard Fairman, CEO
Scott Morrison, Company
Secretary
Peel Hunt LLP (Nominated Adviser & Joint
Broker)
+44 (0)20 7418
8900
Christopher Golden / James Steel /
Andrew Clark / Lalit Bose
Berenberg (Joint Broker)
+44 (0)20 3207
7800
Toby Flaux / Ben Wright / James
Thompson / Milo Bonser
Camarco (Financial
PR)
Ginny Pulbrook
+44 (0)7961 315 138
Geoffrey Pelham-Lane
+44 (0)7733 124 226
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Richard Fairman
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CVS Group plc
|
|
b)
|
LEI
|
213800J41XDQ2NX48O05
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over Ordinary shares
of 0.2 pence each
GB00B2863827
|
|
b)
|
Nature of the transaction
|
Grant of Options under LTIP
18.
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
Exercise price of 0.2p
|
55,581
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
e)
|
Date of the transaction
|
4 October 2024
|
|
f)
|
Place of the transaction
|
Off market
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Robin Alfonso
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CVS Group plc
|
|
b)
|
LEI
|
213800J41XDQ2NX48O05
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over Ordinary shares
of 0.2 pence each
GB00B2863827
|
|
b)
|
Nature of the transaction
|
Grant of Options under LTIP
18.
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
Exercise price of 0.2p
|
30,460
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
e)
|
Date of the transaction
|
4 October 2024
|
|
f)
|
Place of the transaction
|
Off market
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Paul Higgs
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Veterinary Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CVS Group plc
|
|
b)
|
LEI
|
213800J41XDQ2NX48O05
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over Ordinary shares
of 0.2 pence each
GB00B2863827
|
|
b)
|
Nature of the transaction
|
Grant of Options under LTIP
18.
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
Exercise price of 0.2p
|
26,144
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
e)
|
Date of the transaction
|
4 October 2024
|
|
f)
|
Place of the transaction
|
Off market
|